News

STALICLA CEO, Lynn Durham presents STALICLA’s most recent biomarker data at the 2nd Annual Neuroscience Innovation Forum in San Francisco

STALICLA CEO, Lynn Durham presented  STALICLA’s most recent biomarker data yesterday at the 2nd Annual Neuroscience Innovation Forum in San Francisco at the Marines' Memorial Club in San Francisco (USA), prior to the start of the JP Morgan week. 

She also participated in the Expert panel on Advanced in rare and Orphan diseases.

Topics of discussion included pivotal impact of refining patient phenotypical characterization in complexe diseases & optimizing regulatory interactions for small companies with Orphan status or breakthrough designation.

Back to News

Search for content on Stalicla...